Organic Revenue Growth Improvement
Organic revenue growth improved sequentially by 200 basis points, indicating a positive trend despite being flat year-over-year.
Strategic Contract Extensions
Avantor secured significant contract extensions with several top 15 global pharma accounts and BIO Business Solutions, leading to more than $100 million in share gains.
NuSil Platform Performance
NuSil-branded silicones platform grew low double digits, showcasing strong year-to-date growth well ahead of patient procedure counts.
Cost Transformation Program on Track
Avantor remains on track with its cost transformation program, expecting $400 million in run rate savings by the end of 2027.